Vaxcyte Inc
(PCVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 397,048 | 410,046 | 0 | N/A | 0 |
| TOTAL | $400,835 | $413,057 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 2,539 | 2,753 | N/A | N/A | N/A |
| Other Non-Current Assets | 442 | 438 | 0 | 0 | 0 |
| TOTAL | $2,981 | $3,191 | $N/A | $N/A | $N/A |
| Total Assets | $403,816 | $416,248 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,685 | 2,556 | 0 | 0 | 0 |
| Accrued Expenses | 2,870 | 3,297 | 0 | N/A | 0 |
| Other current liabilities | 27 | 25 | 0 | N/A | 0 |
| TOTAL | $39,612 | $32,894 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 129 | 144 | 0 | 0 | 0 |
| TOTAL | $129 | $144 | $N/A | $N/A | $N/A |
| Total Liabilities | $39,741 | $33,038 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,950 | 50,924 | N/A | N/A | N/A |
| Common Shares | 54 | 54 | 0 | N/A | 0 |
| Retained earnings | -177,827 | -156,809 | 0 | N/A | 0 |
| TOTAL | $364,075 | $383,210 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $403,816 | $416,248 | $0 | $0 | $0 |